Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats

Transplantation

Volumn 63, Issue 8, 1997, Pages 1101-1108

  Nagano, Hiroaki ^a   Nadeau, Kari C ^a,b   Takada, Moriatsu ^a   Kusaka, Mamoru ^a   Tilney, Nicholas L ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE SYNTHASE; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GRAFT REJECTION; KIDNEY ALLOGRAFT; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030892738     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00009     Document Type: Article

References (63)

1. Tilney NL, Kupiec-Weglinski J. The biology of acute transplant rejection. Ann Surg 1991; 214: 98.
2. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allografts after treatment with monoclonal antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
3. Maddon P, Littman DR, Godfrey M, Maddon DE, Chess L, Arel R. The isolation and nucleotide sequence of a cDNA encoding the T-cell surface protein T4: a new member of the immunoglobulin superfamily. Cell 1985; 42: 93.
4. Rosenberg AS, Mizuochi T, Sharrow SO, Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.
5. Dallman MJ. Cytokines and transplantation: Thl/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 1995; 7: 632.
6. Pirsch JD, Pleog RJ, Grange S, et al. Determinants of graft survival after renal transplantation. Transplantation 1996; 61: 1581.
7. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularized organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
8. Kondo T, Novick AC, Toma H, Fairchild RL. Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 1996; 61: 1750.
9. Khouly SJ, Hancock W, Weiner HL. Oral tolerance to MBP and natural recovery from encephalomyelitis are associated with down regulation of TGF-β, IL-4 and PGE expression in the brain. J Exp Med 1992; 176: 1335.
10. Chomezynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
11. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine expression in renal allografts in chronic rejection. Proc Natl Acad Sci USA 1995; 60: 1575.
12. Billups KL, Sherley JL, Palladino MA, Tindall JWM, Roberts KP. Evidence for E-selectin complement regulatory domain mRNA splice variants in the rat. J Lab Clin Med 1995; 126: 580.
13. Broad TE, Burkin DJ, Jones C, Lewis PE, Ansari HA. Mapping of MYF5, C1R, MYHL, TPI1, LAPP, A2 MR and RNR onto sheep chromosome 3q. Anim Genet 1993; 24: 415.
14. Minta JO, Wong MJ, Kozak CA, Kunnath-muglia LM, Goldberger G. cDNA cloning, sequencing and chromosomal assignment of the gene for mouse complement factor 1 (C3b/C4b inactivator): identification of a species specific divergent segment in factor I. Mol Immunol 1996; 33: 101.
15. Kurama M, Ishida N, Matsui M, Saida K, Mitsui Y. Sequence and neuronal expression of mouse endothelin-1 cDNA. Biochim Biophys Acta 1996; 1307: 249.
16. Platzer C, Ode-Hakim S, Reinke P, Docke W-D, Ewert R, Volk H-D. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 1994; 58: 264.
17. Chehadeh HE, Zerlauth G, Mannhalter JW. Video image analysis of quantitative competitive PCR products: comparison of different evaluation methods. Biotechniques 1995; 18: 26.
18. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophil related to complement regulatory proteins and lectins. Science 1989; 243: 1160.
19. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425.
20. + memory T lymphocytes induces expression of endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 on the surface of vascular endothelial cells. Eur J Immunol 1991; 21: 2915.
21. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P-selectin-deficient mice. Cell 1993; 74: 541.
22. Ohmori K, Takada A, Ohwaki I, et al. A distinct type of sialyl lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells. Blood 1993; 9: 2797.
23. Ferran C, Peuchmaur M, Desruennes M, et al. Implication of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejection. Transplantation 1993; 55: 605.
24. Abbas AK, Lichtman AH, Pober JS, eds. Cellular and molecular immunology. In: The complement system. Philadelphia: WB Saunders, 1994: 293.
25. Baldwin WM III, Pruitt SK, Brauer RB, Daha MR, Sanflippo F. Complement in organ transplantation: contribution to inflammation, injury, and rejection. Transplantation 1995; 59: 797.
26. Peerschke EI, Reid KBM, Ghebrehiwet B. Identification of a novel 33-kDa V1q-binding site on human blood platelets. J Immunol 1994; 179: 1809.
27. Ghebreiwet B, Lim BL, Peerschke EI, Willis AC, Reid KB. Isolation, cDNA cloning and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med 1994; 179: 1809.
28. Erdei A, Fust G, Gergery J. The role of C3 in immune response. Immunol Today 1991; 12: 332.
29. Brauer RB, Lam TT, Wang D, et al. Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft. Transplantation 1995; 59: 1073.
30. Johnson E, Hetland G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol 1988; 27: 489.
31. Houle JJ, Leddy JP, Rosenfeld SI. Secretion of the terminal complement proteins, C5-C9, by human platelets. Clin Immunol Immunopathol 1989; 59: 385.
32. Pantazis P, Kalyanaraman VS, Bing DH. Synthesis of the third component of complement (C3) by lectin activated and HTLV-infected human T cells. Mol Immunol 1990; 27: 283.
33. Johnson E, Hetland G. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vivo. Scand J Immunol 1991; 33: 667.
34. Brooimans RA, Stegmann AP, van Dorp WT, et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991; 88: 379.
35. Andrews PA, Finn JE, Lloid CM, Zhou W, Mathieson PW, Sachs SH. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 1995; 25: 1087.
36. Sacks K, Zhou W, Campbell RD, Martin J. C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 1993; 93: 411.
37. Baldwin WM III, Hendry W, Birinyi LK Jr, Tilney NL. Immune responses to organ allografts: I - intense B cell response to heart allografts in lymphoid tissues of unmodified rats. Lab Invest 1979; 40: 695.
38. Pattison J, Nelson PJ, Huie P, Krensky A. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 343: 209.
39. Vanotteren G, Strieter R, Kunkel S, et al. Compartmentalized expression of RANTES in a murine model of endotoxemia. J Immunol 1995; 154: 1900.
40. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells. J Immunol 1995; 154: 1870.
41. Sherwan H, Cramer DV. Prevention of orthotopic liver allograft rejection in rats: analysis of intragraft cytokine gene expression. Transplantation 1994; 57: 1072.
42. Doherty PC. Cell-mediated cytotoxicity. Cell 1993; 75: 607.
43. Johnson CP, Chaharmohal A, Buchman E, Roza Am, Adams MB. Plasma IL-2R levels and diagnosis of renal transplant rejection. Transplant Proc 1990; 22: 1849.
44. Rosa F, Fellous M. The effect of gamma-interferon on MHC antigens. Immunol Today 1984; 5: 261.
45. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158: 670.
46. Paul WE, Ohara J. B cell stimulatory factor-1/interleukin-4. Annu Rev Immunol 1987; 5: 429.
47. Disiovin FS, Duff GW. Interleukin 1: the first interleukin. Immunol Today 1990; 14: 65.
48. Van Oers MH, Van der Heyden AA, Arden LA. Interleukin 6 (IL-6) in serum and urine of renal transplantation recipients. Clin Exp Immunol 1988; 71: 314.
49. Jerinek DF, Lipsky PE. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-a and interleukin 1. J Immunol 1987; 139: 2970.
50. Hirano T, Shizuo A, Taga T, Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 1990; 11: 443.
51. Nothermann W, Braciak TA, Hattori M, Lee F, Fey GH. Structure of rat interleukin gene and its expression in macrophage-derived cells. J Biol Chem 1989; 264: 16.
52. Garman RD, Jacobs KA, Clark SC, Ravlet DH. B cell-costinulatory factor 2 (b2 interferon) function as a second signal for interleukin 2 production by mature T cells. Proc Natl Acad Sci USA 1987; 84: 7629.
53. Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J Immunol 1988; 140: 531.
54. Scheurich P, Thoma B, Ucer U, Pfizenmaier K. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 1987; 138: 1786.
55. Xie QW, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225.
56. Lorsbach RB, Murphy WJ, Lowenstein CJ, Snyder SH, Russell SW. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem 1993; 268: 1908.
57. Yang X, Chowdhury N, Cai B, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994; 94: 714.
58. Weinberg JB, Granger D, Pisetsky D, et al. The role of NO in the pathogenesis of spontaneous murine autoimmune disease. J Exp Med 1994; 179: 651.
59. Border WA, Nobel NA. Transforming growth β in tissue fibrosis. N Engl J Med 1994; 331: 1286.
60. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411.
61. Watschinger B, Vychytil A, Schuller M, et al. Pathophysiological role of endothelin in acute vascular rejection after renal transplantation. Transplantation 1991; 52: 743.
62. Watchinger B, Sayegh MH, Hancock WW, Russell ME. Up-regulation of endothelin-1 m RNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol 1995; 146: 1065.
63. Ohta K, Hirata Y, Imai T, et al. Cytokine induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun 1990; 169: 578.